CLINICAL ENDOCRINOLOGY, vol.67, no.6, pp.904-908, 2007 (SCI-Expanded)
Objective There are conflicting data regarding the effects of metformin in lean women with polycystic ovary syndrome (PCOS). Thus, our aim was to evaluate the effects of 6 months of metformin therapy on various metabolic and cardiovascular risk factors in lean women with PCOS.